Eli Lilly says its oral GLP-1 drug, orforglipron, can be taken once a day at any time without food or water restrictions
Secondary Research The market for the companies offering GLP-1 agonists is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, their revenue mapping, and rating the companies by their performance and quality
These findings represent substantial improvements over traditional anti-obesity medications and approach the efficacy levels historically associated with bariatric surgery
Multiple studies have tied changes in the gut microbiome to lower GLP-1 levels, but the mechanism isnt always clearly defined
Frequently Asked Questions How does retatrutide's triple mechanism differ functionally from tirzepatide
If you post comments, pictures, or other content via public forums that may be available on the Services, that information may be publicly available